504 related articles for article (PubMed ID: 29113975)
21. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
[TBL] [Abstract][Full Text] [Related]
22. The carboxyl termini of RAN translated GGGGCC nucleotide repeat expansions modulate toxicity in models of ALS/FTD.
He F; Flores BN; Krans A; Frazer M; Natla S; Niraula S; Adefioye O; Barmada SJ; Todd PK
Acta Neuropathol Commun; 2020 Aug; 8(1):122. PubMed ID: 32753055
[TBL] [Abstract][Full Text] [Related]
23. Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD.
Zhou B; Liu C; Geng Y; Zhu G
Sci Rep; 2015 Nov; 5():16673. PubMed ID: 26564809
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
Wen X; Westergard T; Pasinelli P; Trotti D
Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
[TBL] [Abstract][Full Text] [Related]
25. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS.
Gitler AD; Tsuiji H
Brain Res; 2016 Sep; 1647():19-29. PubMed ID: 27059391
[TBL] [Abstract][Full Text] [Related]
26. A synthetic Pur-based peptide binds and alters G-quadruplex secondary structure present in the expanded RNA repeat of C9orf72 ALS/FTD.
Wortman MJ; Dagdanova AV; Clark AM; Godfrey EW; Pascal SM; Johnson EM; Daniel DC
Biochim Biophys Acta Mol Cell Res; 2020 Jun; 1867(6):118674. PubMed ID: 32035967
[TBL] [Abstract][Full Text] [Related]
27. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
28. Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD.
Starr A; Sattler R
Brain Res; 2018 Aug; 1693(Pt A):98-108. PubMed ID: 29453960
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation.
Cheng W; Wang S; Zhang Z; Morgens DW; Hayes LR; Lee S; Portz B; Xie Y; Nguyen BV; Haney MS; Yan S; Dong D; Coyne AN; Yang J; Xian F; Cleveland DW; Qiu Z; Rothstein JD; Shorter J; Gao FB; Bassik MC; Sun S
Neuron; 2019 Dec; 104(5):885-898.e8. PubMed ID: 31587919
[TBL] [Abstract][Full Text] [Related]
30. RNA-mediated toxicity in C9orf72 ALS and FTD.
McEachin ZT; Parameswaran J; Raj N; Bassell GJ; Jiang J
Neurobiol Dis; 2020 Nov; 145():105055. PubMed ID: 32829028
[TBL] [Abstract][Full Text] [Related]
31. C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A.
Moens TG; Niccoli T; Wilson KM; Atilano ML; Birsa N; Gittings LM; Holbling BV; Dyson MC; Thoeng A; Neeves J; Glaria I; Yu L; Bussmann J; Storkebaum E; Pardo M; Choudhary JS; Fratta P; Partridge L; Isaacs AM
Acta Neuropathol; 2019 Mar; 137(3):487-500. PubMed ID: 30604225
[TBL] [Abstract][Full Text] [Related]
32. Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD.
Moens TG; Mizielinska S; Niccoli T; Mitchell JS; Thoeng A; Ridler CE; Grönke S; Esser J; Heslegrave A; Zetterberg H; Partridge L; Isaacs AM
Acta Neuropathol; 2018 Mar; 135(3):445-457. PubMed ID: 29380049
[TBL] [Abstract][Full Text] [Related]
33. Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases.
Riboldi G; Zanetta C; Ranieri M; Nizzardo M; Simone C; Magri F; Bresolin N; Comi GP; Corti S
Mol Neurobiol; 2014 Dec; 50(3):721-32. PubMed ID: 24809691
[TBL] [Abstract][Full Text] [Related]
34. Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models.
Yuva-Aydemir Y; Almeida S; Gao FB
Trends Neurosci; 2018 Jul; 41(7):457-469. PubMed ID: 29729808
[TBL] [Abstract][Full Text] [Related]
35. The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation.
Tseng YJ; Sandwith SN; Green KM; Chambers AE; Krans A; Raimer HM; Sharlow ME; Reisinger MA; Richardson AE; Routh ED; Smaldino MA; Wang YH; Vaughn JP; Todd PK; Smaldino PJ
J Biol Chem; 2021 Aug; 297(2):100914. PubMed ID: 34174288
[TBL] [Abstract][Full Text] [Related]
36. Characterizations of distinct parallel and antiparallel G-quadruplexes formed by two-repeat ALS and FTD related GGGGCC sequence.
Zhou B; Geng Y; Liu C; Miao H; Ren Y; Xu N; Shi X; You Y; Lee T; Zhu G
Sci Rep; 2018 Feb; 8(1):2366. PubMed ID: 29402965
[TBL] [Abstract][Full Text] [Related]
37. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
Tomiyama H
Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
[TBL] [Abstract][Full Text] [Related]
38. SFPQ regulates the accumulation of RNA foci and dipeptide repeat proteins from the expanded repeat mutation in
Malnar M; Rogelj B
J Cell Sci; 2021 Feb; 134(4):. PubMed ID: 33495278
[TBL] [Abstract][Full Text] [Related]
39. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions.
Cooper-Knock J; Walsh MJ; Higginbottom A; Robin Highley J; Dickman MJ; Edbauer D; Ince PG; Wharton SB; Wilson SA; Kirby J; Hautbergue GM; Shaw PJ
Brain; 2014 Jul; 137(Pt 7):2040-51. PubMed ID: 24866055
[TBL] [Abstract][Full Text] [Related]
40. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
